Centrus IPO Presentation Deck slide image

Centrus IPO Presentation Deck

Pioneering High-Assay, Low Enriched Uranium (HALEU) What is HALEU? Potential HALEU Requirements from Advanced Reactors MTU HALEU (19.75%-equivalent) HALEU is uranium that has been enriched in U- 235 up to 20%, compared to the 4-5% level used in today's commercial reactors • Higher U-235 concentration = smaller fuel cores, smaller reactors, more efficient fuel consumption, longer periods between refueling, and reduced waste production. Centrus HALEU Enrichment Plant • Under a contract with the U.S. Department of Energy, Centrus is building the only U.S. facility that will be licensed to produce HALEU 80/20 USG-Centrus cost-share, with USG contribution capped at $115MM Leverages proven centrifuge technology Scheduled completion 2022 and will have a NRC license to enrich up to 20% • Initial capacity is demonstration scale - enough to fuel 1-2 small reactors- but can be expanded modularly to meet any level of demand Centrus Metric Tone HALEU (MTU) **** US DOMs High Temp Gas Reactors Chart does not include potential HALEU demand for accident- tolerant fuel designs for existing reactors (up to 500 MTUy HALEU) U.S. Department of Energy Centrus AC100 centrifuge design is the "most advanced," "least risk" option to meet U.S. national security requirements
View entire presentation